PGNY Stock — Progyny Inc.

Progyny Inc. (PGNY)

Updated October 16, 2026.

PGNY is a Stock. Total return is 68.5% over the past 7 years, 111.2 points behind SPY at 179.7%.

Progyny, Inc. is a benefits management company that provides fertility, family building, and women's health solutions to employers and their employees in the United States. Its offerings include fertility benefits with personalized member support, an integrated pharmacy benefits solution for treatment medications, pregnancy and postpartum care, and assistance programs covering adoption, surrogacy, and related services. The company does not currently distribute dividends to shareholders.

PGNY performance versus SPY

Price and return data through 2026-10-16.

Total return is 68.5% over the past 7 years, 111.2 points behind SPY at 179.7%. Over the past year its total return — price change plus distributions reinvested — is 25.9%. Its deepest 1-year drawdown was 42.6%.

PGNY key facts

Asset type

Stock

Asset class

Equity

Inception date

10/25/2019

Distribution frequency

None

Last close

$26.86 (as of 2026-10-16)

Market cap

$2,060,881,794

Average volume

919546.0

Beta

1.02

Payout ratio

0.0%

P/E ratio

29.2

Forward P/E

11.8483

EPS

$0.92

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PGNY risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 42.6%.

Who may consider PGNY — and who may not

It is a weaker fit for investors who need monthly cash flow (PGNY does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PGNY

• All tickers starting with P

Tagged: Healthcare.

Frequently asked questions